These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25113794)

  • 21. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
    Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Alzheimer's disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers.
    Grønning H; Rahmani A; Gyllenborg J; Dessau RB; Høgh P
    Dement Geriatr Cogn Disord; 2012; 33(2-3):111-7. PubMed ID: 22508568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulcal morphology as a new imaging marker for the diagnosis of early onset Alzheimer's disease.
    Hamelin L; Bertoux M; Bottlaender M; Corne H; Lagarde J; Hahn V; Mangin JF; Dubois B; Chupin M; de Souza LC; Colliot O; Sarazin M
    Neurobiol Aging; 2015 Nov; 36(11):2932-2939. PubMed ID: 26256787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in cortical thickness with dementia severity in Alzheimer's disease.
    Im K; Lee JM; Seo SW; Yoon U; Kim ST; Kim YH; Kim SI; Na DL
    Neurosci Lett; 2008 May; 436(2):227-31. PubMed ID: 18400396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of amyloid-β burden with age-at-onset in Alzheimer disease.
    Choo IH; Lee DY; Kim JW; Seo EH; Lee DS; Kim YK; Kim SG; Park SY; Woo JI; Yoon EJ
    Am J Geriatr Psychiatry; 2011 Jul; 19(7):627-34. PubMed ID: 21709608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in routine clinical practice between early and late onset Alzheimer's disease: data from the Swedish Dementia Registry (SveDem).
    Eriksson H; Fereshtehnejad SM; Falahati F; Farahmand B; Religa D; Eriksdotter M
    J Alzheimers Dis; 2014; 41(2):411-9. PubMed ID: 24614905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic normal-pressure hydrocephalus, cortical thinning, and the cerebrospinal fluid tap test.
    Kang K; Yoon U; Lee JM; Lee HW
    J Neurol Sci; 2013 Nov; 334(1-2):55-62. PubMed ID: 23938354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical damage in Alzheimer's disease estimation in medial and lateral aspects of the cerebrum using an improved mapping method based on diffusion-weighted magnetic resonance imaging.
    Yoshiura T; Noguchi T; Koga H; Ohyagi Y; Hiwatashi A; Togao O; Yamashita K; Kumazawa S; Mihara F; Honda H
    Acad Radiol; 2008 Feb; 15(2):193-200. PubMed ID: 18206618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging.
    Parker TD; Slattery CF; Zhang J; Nicholas JM; Paterson RW; Foulkes AJM; Malone IB; Thomas DL; Modat M; Cash DM; Crutch SJ; Alexander DC; Ourselin S; Fox NC; Zhang H; Schott JM
    Hum Brain Mapp; 2018 Jul; 39(7):3005-3017. PubMed ID: 29575324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct fiber-specific white matter reductions pattern in early- and late-onset Alzheimer's disease.
    Luo X; Wang S; Jiaerken Y; Li K; Zeng Q; Zhang R; Wang C; Xu X; Wu D; Huang P; Zhang M;
    Aging (Albany NY); 2021 Apr; 13(9):12410-12430. PubMed ID: 33930871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study.
    Pievani M; Bocchetta M; Boccardi M; Cavedo E; Bonetti M; Thompson PM; Frisoni GB
    Neurobiol Aging; 2013 Jul; 34(7):1728-39. PubMed ID: 23428181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions.
    Chen SQ; Kang Z; Hu XQ; Hu B; Zou Y
    J Zhejiang Univ Sci B; 2007 Apr; 8(4):242-7. PubMed ID: 17444598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.
    Eskildsen SF; Coupé P; Fonov VS; Pruessner JC; Collins DL;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S23-31. PubMed ID: 25260851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage.
    Canu E; Frisoni GB; Agosta F; Pievani M; Bonetti M; Filippi M
    Neurobiol Aging; 2012 Jun; 33(6):1023-33. PubMed ID: 21074899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease.
    Zhu WZ; Zhong WD; Wang W; Zhan CJ; Wang CY; Qi JP; Wang JZ; Lei T
    Radiology; 2009 Nov; 253(2):497-504. PubMed ID: 19709998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
    Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
    J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.